Stage 2 clear cell renal cell carcinoma is typically curable, especially when detected early. Surgery remains the cornerstone of treatment, with excellent outcomes in many cases. Patients are ...
Clear cell odontogenic carcinoma (CCOC) is a rare malignant neoplasm of odontogenic origin that predominantly affects the jawbones, particularly the mandible. Typically presenting in middle-aged to ...
The LARA trial (NCT04699071), a multi-center, single-arm, phase 2 study, found that combining pembrolizumab (Keytruda) with ...
Select patients with oligometastatic ccRCC might be managed with a period of metastasis-directed therapy alone. Serial metastasis-directed radiation therapy may delay systemic therapy in clear cell ...
CAR T-cell therapy is being adapted for clear cell renal cell carcinoma, targeting CAIX and CD70 to improve efficacy and safety. Early trials like COBALT-RCC and TRAVERSE show promising disease ...
Leveraging tumor organoids to model drug response in clear cell renal cell carcinoma. % Reactive Fragments 65.2 ± 26.8 43.0 ± 46.2 % CD56 + of TIL Expansion 14.1 ± 26.2 9.8 ± 4.6 % CD3 + of TIL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results